Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections, including those caused by many of the multidrug-resistant (MDR) bacteria highlighted as urgent public health threats by the CDC.
REPORT RATINGS
4.8 / 5.0 (103)
Tetraphase Pharma Inc reports have an aggregate usefulness score of 4.8 based on 103 reviews.